m+Medelevator.RU
← Поиск публикаций
Materials today. Bio · 2026

Interfacial mild alkalinity shapes Neutrophil immunometabolism through sphingolipid remodeling to enhance antibacterial host defense.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zheng Gaoquan, Li Dianqing, Zheng Dengwen, Liu Yupeng, He Yaxi, Jiang Jialin, Zhang Dongdong, Zhang Xiurui, Tong Liping, Peng Feng, Yu Xiang, Li Mei

Аннотация

Implant-associated infection is commonly addressed by surfaces designed for direct bacterial killing, yet early host immune events at the implant interface are critical for infection outcome. Here, we designed Ti-A, a mildly alkaline titanium interface, to examine whether interfacial pH could act as an immune-regulatory cue for host-directed infection control. Ti-A showed acceptable cytocompatibility and promoted neutrophil extracellular traps (NETs) formation, thereby enhancing neutrophil-mediated killing of S. aureus. The attenuation of antibacterial activity after DNase I treatment supported the functional contribution of NETs. Metabolomic and molecular analyses further suggested that sphingolipid remodeling may converge on enhanced SPHK1-S1PR2/ROS signaling during Ti-A-induced NET formation. In a bacteria-loaded implant-induced bone defect model, Ti-A reduced local bacterial burden with evidence of NET-associated host defense at the infected interface. Importantly, this immune-antibacterial response did not compromise bone repair; Ti-A preserved osteogenic activity, promoted matrix mineralization, and improved infected bone defect repair without evident systemic toxicity. These findings identify mild interfacial alkalinity as a material-encoded cue that tunes neutrophil immunometabolism toward NET-mediated infection control while supporting subsequent bone regeneration.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты